Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Biochemical Insights into Progeria Syndrome Identify Bisphosphonates, Statins as Possible Candidate Drugs to Halt Aging

Simon M. Helfgott, MD  |  Issue: August 2016  |  August 10, 2016

One of the key investigators in the field created a company to commercialize the science of resveratrol that was purchased about 10 years ago by one of the large multinational pharmaceutical companies for over $700M.9 As is wont in scientific research, what looks to be a surefire hit often turns out to be a giant miss. Subsequent research hit a wall; resveratrol was an unstable compound to administer to subjects, its blood levels fluctuated greatly, and its effect varied widely with its concentration. Perhaps most critically for the new owners, resveratrol, being a natural compound, could not be patented as a drug. Five years after its purchase, the company folded.10

Better to Burn Out or to Rust?

Reversing aging will remain a vexing challenge for decades—if not centuries—to come. Drinking red wine is pleasurable, and perhaps doing so prolongs life. Some individuals have adopted a different approach. Take Google’s leading futurist, Ray Kurzweil, a fervent believer that dietary modifications “can help him live forever.”11 He has predicted that humans will achieve this target by 2045, the year he turns 97. By his own admission, he spends upward of $1M per year ingesting about 100 various vitamins and supplements daily in an effort to enhance his health and delay the aging process. Good luck, Ray, and I hope Google’s stock price stays high!

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

For the rest of us, aging is a phenomenon that we have come to accept and, at times even embrace. Indeed, natural aging creates a pattern of predictability to our illnesses. For example, we don’t anticipate gout’s arrival before the fourth decade of life, nor should we expect to see the imprint of Drs. Charles Bouchard or William Heberden’s observations in the hands until some years later. Of course, it is uncanny how we can accurately predict when the alarm is set for developing polymyalgia rheumatica (PMR), a condition that is inextricably linked to one’s eligibility date for membership in the AARP and not a day sooner!

Let’s face it, life is a finite event. … Death is programmed inside every living organism, & this is a fact of life.

Let’s face it, life is a finite event. Despite Mr. Kurzweil’s unbridled optimism, this will likely remain the state of affairs for the next millennium and possibly beyond. Death is programmed inside every living organism, and this is a fact of life. This is simply Nature’s way of drawing the circle, linking life with death.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Career DevelopmentEducation & TrainingProfessional TopicsResearch Rheum Tagged with:agingbisphosphonatesClinicalDrugspatient careResearchrheumatologyStatintherapy

Related Articles

    What Mick Jagger Can Teach Us About Growing Old Gracefully

    February 1, 2013

    Preventive lifestyle behaviors, including regular exercise, can compress morbidity and disability to the very end of our lives, say rheumatologists

    Anti-Mitochondrial Antibodies & Systemic Lupus Erythematosus

    April 29, 2019

    Although antimitochondrial antibodies are present in SLE patients, researchers have has difficulty investigating the phenomenon due to barriers in isolating pure mitochondria. The study describes a technique that allows for such an investigation and provides insight into how the adaptive immune system recognizes mitochondrial organelles…

    Diagnosis: Myopathy

    July 1, 2009

    Presentation and evaluation of metabolic causes

    New Insights into CPPD

    October 1, 2013

    Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences